Review
doi: 10.2174/15733998113099990002.Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin
Affiliations
- PMID:23627783
- DOI: 10.2174/15733998113099990002
Item in Clipboard
Review
Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin
Michael P Bogenschutz. Curr Drug Abuse Rev.2013 Mar.
Display options
Format
Display options
Format
Abstract
Recent developments in the study of classic hallucinogens, combined with a re-appraisal of the older literature, have led to a renewal of interest in possible therapeutic applications for these drugs, notably their application in the treatment of addictions. This article will first provide a brief review of the research literature providing direct and indirect support for the possible therapeutic effects of classic hallucinogens such as psilocybin and lysergic acid diethylamide (LSD) in the treatment of addictions. Having provided a rationale for clinical investigation in this area, we discuss design issues in clinical trials using classic hallucinogens, some of which are unique to this class of drug. We then discuss the current status of this field of research and design considerations in future randomized trials.
Similar articles
- Therapeutic Applications of Classic Hallucinogens.Bogenschutz MP, Ross S.Bogenschutz MP, et al.Curr Top Behav Neurosci. 2018;36:361-391. doi: 10.1007/7854_2016_464.Curr Top Behav Neurosci. 2018.PMID:28512684Review.
- d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G.De Gregorio D, et al.Prog Brain Res. 2018;242:69-96. doi: 10.1016/bs.pbr.2018.07.008. Epub 2018 Aug 31.Prog Brain Res. 2018.PMID:30471683Review.
- Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses.Bogenschutz MP, Pommy JM.Bogenschutz MP, et al.Drug Test Anal. 2012 Jul-Aug;4(7-8):543-55. doi: 10.1002/dta.1376. Epub 2012 Jul 4.Drug Test Anal. 2012.PMID:22761106Review.
- Classic hallucinogens in the treatment of addictions.Bogenschutz MP, Johnson MW.Bogenschutz MP, et al.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:250-8. doi: 10.1016/j.pnpbp.2015.03.002. Epub 2015 Mar 14.Prog Neuropsychopharmacol Biol Psychiatry. 2016.PMID:25784600Review.
- [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Majić T, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J.Majić T, et al.Fortschr Neurol Psychiatr. 2017 Jul;85(7):383-392. doi: 10.1055/s-0043-103085. Epub 2017 Aug 2.Fortschr Neurol Psychiatr. 2017.PMID:28768346Review.German.
Cited by
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE.Dos Santos RG, et al.Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. doi: 10.1177/2045125316638008. Epub 2016 Mar 18.Ther Adv Psychopharmacol. 2016.PMID:27354908Free PMC article.Review.
- The serotonin 2A receptor agonist TCB-2 attenuates heavy alcohol drinking and alcohol-induced midbrain inhibitory plasticity.Kimmey BA, Wittenberg RE, Croicu A, Shadani N, Ostroumov A, Dani JA.Kimmey BA, et al.Addict Biol. 2022 Mar;27(2):e13147. doi: 10.1111/adb.13147.Addict Biol. 2022.PMID:35229942Free PMC article.
- Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen Und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH.Meinhardt MW, et al.Sci Adv. 2021 Nov 19;7(47):eabh2399. doi: 10.1126/sciadv.abh2399. Epub 2021 Nov 17.Sci Adv. 2021.PMID:34788104Free PMC article.
- Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.Vorobyeva N, Kozlova AA.Vorobyeva N, et al.Front Pharmacol. 2022 Jun 28;13:927984. doi: 10.3389/fphar.2022.927984. eCollection 2022.Front Pharmacol. 2022.PMID:35837277Free PMC article.Review.
- Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA.Calleja-Conde J, et al.Addict Biol. 2022 Nov;27(6):e13229. doi: 10.1111/adb.13229.Addict Biol. 2022.PMID:36301215Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical